What is the infectious disease therapeutics market?

The infectious disease therapeutics market focuses on the development and distribution of drugs and treatments for infectious diseases, including vaccines, antibiotics, antivirals, antifungals, and antiparasitics.

How big is the Infectious Disease Therapeutics Market?

The global Infectious Disease Therapeutics Market size was estimated at USD 69.1 Billion in 2023 and is expected to reach USD 132.8 Billion in 2033.

What is the Infectious Disease Therapeutics Market growth?

The global Infectious Disease Therapeutics Market is expected to grow at a compound annual growth rate of 6.8%. From 2024 To 2033

Who are the key companies/players in the Infectious Disease Therapeutics Market?

Some of the key players in the Infectious Disease Therapeutics Markets are Novartis AG , Gilead Sciences, Inc., GSK plc., Janssen Pharmaceutica NV, F. Hoffmann-La Roche Ltd., BioCryst Pharmaceuticals, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Merck & Co., Inc., AbbVie Inc., Pfizer Inc., Moderna, Inc.

Which regions are leading in the Infectious Disease Therapeutics market?

North America dominating the market capturing a huge market revenue share of 38.41% in the year 2023.

What factors are driving the growth of this market?

The market is driven by the increasing prevalence of infectious diseases, global pandemics like COVID-19, rising antimicrobial resistance, and significant investments in research and development for new therapeutics.

What are the challenges faced by the market?

Key challenges include the high cost of drug development, regulatory hurdles, and the growing issue of antimicrobial resistance, which complicates the treatment of bacterial infections.

Global Infectious Disease Therapeutics Market By Disease Type (HIV, Hepatitis, Influenza, TB, Malaria, and Others), By Treatment Type (Antibiotics, Antiviral Drugs, Antifungal Drugs, Antiparasitic Drugs, and Others), By End-use (Hospitals, Clinics, and Others), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2024-2033

Published date: Aug 2024
Report ID: 126309
Number of Pages: 206
Format:

Overview
Table of Contents
Major Market Players
Request a Free Sample

- Novartis AG
- Gilead Sciences, Inc.
- GSK plc.
- Janssen Pharmaceutica NV
- Hoffmann-La Roche Ltd.
- BioCryst Pharmaceuticals, Inc.
- Boehringer Ingelheim Pharmaceuticals, Inc.
- Merck & Co., Inc.
- AbbVie Inc.
- Pfizer Inc.
- Moderna, Inc.